RightFit
RecruitingNot applicable

Home Blood Transfusions

A Pilot Study of Home Blood Transfusions for Patient With Cancer Who Have Transfusion Dependent Cytopenias

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Time periods mentioned: 5 weeks
  • Procedures mentioned: Blood draws, Questionnaires, Interviews

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Participants will receive home blood draws and if needed same day transfusions."
  • "Data will be collected via surveys at time of each study visit, participant surveys at the end of the intervention as well as a semi structured interview."
  • "As a result each participant will be eligible to receive transfusions at home for 5 weeks."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This small study tests whether giving blood transfusions at home is practical and acceptable to patients. It is for people with blood cancers or diseases in which bone marrow does not make enough blood cells, who need regular transfusions and want home care. Participants will receive 1–5 units of blood products at home and share feedback through surveys and interviews.

This is a pilot single arm study to evaluate the feasibility and acceptability of a home blood transfusion program. Patients will be enrolled with hematologic malignancies and other bone marrow failure syndromes who are transfusion dependent and interested in a home blood transfusion program. Participants enrolled in the study will receive 1-5 units of blood products at home. Data on barriers to administration will be recorded. Surveys and qualitative interviews will be completed to better understand acceptability of the program.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Be older than 18.
  • Sign and date a consent form agreeing to join the study.
  • Be willing to follow all study steps and be available for the whole study.
  • Need at least 2 blood product transfusions in a 28-day period.
  • Receive your cancer care at SKCCC.
  • Have received blood products before, with no past transfusion reactions.
  • Live within 30 miles of the Center City SKCCC location.
  • Be willing to let people into your home.

Who can't join

  • Have had a reaction to a blood transfusion.
  • Have heart failure rated as AHA stage C or NYHA class II–IV, which describe certain levels of heart failure.
  • Do not speak English or Spanish.
  • Do not have housing.
  • Are in jail or prison.
  • Have veins that are hard to use for transfusions.
  • Have a solid tumor cancer, rather than a blood cancer.
  • Are pregnant.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Individuals must meet all of the following inclusion criteria in order to be eligible to participate in the study: * Provide signed and dated informed consent form Willing to comply with all study procedures and be available for the duration of the study * Male or female, over the age of 18 * Must meet definition of transfusion dependence (require at least 2 blood product transfusions over a 28-day period) * Receive their cancer care at SKCCC * Have a history of blood product transfusions and NO history of transfusion reactions, * Live within a 30-mile range of the Center City SKCCC location. * Must be willing to allow people into the home Exclusion Criteria: * An individual who meets any of the following criteria will be excluded from participation in this study: * Patients who have a history of a transfusion reaction * Heart failure as defined by AHA stage C or NYHA Class II-IV * Non-English or Spanish speaking * Are unhoused * Are incarcerated * Have poor venous access * Diagnosis of Solid Tumor malignancy * Women who are pregnant

Study sites (1)

PA